Barajas-Gamboa, Juan S.
Restrepo-Rodas, Gabriela
Mocanu, Valentin
Wills, Mélissa V.
Shin, Thomas H.
Kachornvitaya, Pattharasai
Romero-Velez, Gustavo
Zhu, Xinlei
Strong, Andrew T.
Navarrete, Salvador
Corcelles, Ricard
Guerron, A Daniel
Rodriguez, John
Kroh, Matthew
Dang, Jerry T.
Article History
Received: 29 July 2025
Revised: 18 March 2026
Accepted: 22 March 2026
First Online: 25 March 2026
Declarations
:
: Matthew Kroh serves as Chief Medical Officer for Core Surgical Innovation, Medtronic. This position is unrelated to the current study, and there are no financial or commercial associations between this research and Medtronic or any of its products. All other authors declare no competing financial or non-financial interests relevant to this work.
: Preliminary results from this study were presented as a poster at SAGES 2025 (Long Beach, California); however, this manuscript represents the complete analysis and has not been published elsewhere.
: This study was exempt from institutional review board approval as the MBSAQIP Participant User File (PUF) contains only de-identified patient data.
: Informed consent was waived for this retrospective study in accordance with institutional and national research ethics guidelines.